Stockreport

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Cullinan Therapeutics, Inc.  (CGEM) 
PDF CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality- [Read more]